Friendly reminder that the deadline for the Red Journal SBRT special issue is June 30. It's going to be a great issue, with more than 100 submissions already!
Hey #radoncs! Quadshot News is looking for financial support to continue their outstanding work. They are one of my go-to avenues to keep up in the oncology world. I get a short email every day that highlights a few key papers.
Consider a donation to keep them up and running: quadshotnews.com
We are looking to feature research focused on: 1) Growing the evidence base for SBRT 2) Clinical implementation of SBRT 3) Technical or biological innovation in SBRT
Todas is HCC day! - RTOG 1112 - HCC unsuitable for or refractory to local-regional Tx (n=177) - SBRT & Sorafenib vs Sorafenib - After adjustment for stratification factors, improved OS after SBRT (HR 0.72) - Median PFS improved from 5.5 to 9.2 mo (HR 0.55) jamanetwork.com/journals/jam...
Safe practice of spine SBRT requires high-quality data about SC dose tolerance - Cohort study 2051 pts - 30 cases of RM, 19 of which G3 to G4 - 2a rate of G1-4 RM 1.8% - cord dose D0.1cc of 19.1Gy / Dmax of 20.8Gy = 1.0% risk of G3 to G4 RM at 2 years jamanetwork.com/journals/jam...
